
IDC-10 Code = C49.9
Genomic coordinate (human 12:50,763,459 ATF1 & mouse 15:100,125,729 Atf1).
Cytoband (human 12q13.12 ATF1 & mouse 15f3 Atf1).
Cytoband Position (0.4=human 12q13.12 & 1.0=mouse 15f3).
Intraband %= 86% ATF1 human.
OMIM’ genes @ 12q13.12 = 15 genes.
ClinVar = 59 ATF1 variants, with 3 pathogenic.
Hyperbolic Umbilic Chromosome-12 is 1,200 genes.
Chromosome-12 Cytobands: WG2B2GC_CBG5B2G6
Chromosome-15 Cytobands: BGBGBG4
Here I present: “Clear Cell Sarcoma”, Victor McKusick, Mendelian Inheritance in Man’, 1966. (ARF1)
Clear cell sarcoma (CCS) is an aggressive type of soft tissue cancer that typically develops in the deep tendons and connective tissues of the extremities, such as the feet, ankles, hands, and knees. It predominantly affects young adults in their 20s to 40s years of age.
Symptoms and Causes
- Common signs: A slow-growing, often painless or tender lump under the skin; swelling; or restricted movement if near a joint.
- Underlying cause: It is driven by a genetic abnormality—specifically a chromosomal translocation (usually t(12;22)) that fuses the EWSR1 and ATF1
- Cell appearance: Named because the tumor cells look clear or pale under a microscope, it was historically called “malignant melanoma of the soft parts” due to shared melanocytic markers.
- Normal Regulation (Blue Valley): Represents the homeostatic state of a healthy cell. Under normal conditions, wild-type ATF1 (Activating Transcription Factor-1) is strictly regulated by external signals and baseline cAMP Signaling.
- Fusion State (Yellow Ridge): Represents the critical turning point caused by the chromosomal translocation that fuses the EWSR1 and ATF1 genes. This chimeric EWSR1::ATF1 protein acts as a constitutive, hyperactive transcription factor.
- Oncogenic Activation (Red Slope/Valley): Displays the destination state toward which the white arrow points. The aberrant fusion protein permanently hijacks the cell’s machinery, driving uncontrolled growth and tumor development.
- cAMP Signaling (X-Axis): The physiological biochemical pathway that usually controls ATF1 activation.
- Transcriptional Activity (Y-Axis): The rate and intensity at which downstream target genes are expressed.
- Genomic Reprogramming (Z-Axis/Vertical): The global shift in the chromatin landscape and epigenetic state, moving the cell away from its original identity toward a malignant cancer phenotype.




